Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | RET | P07949 | 1/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 5/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 4/20 | 0.41 |
| ▸ | KDR | P35968 | 4/20 | 0.41 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.41 |
| ▸ | CDK1 | P06493 | 2/20 | 0.41 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.41 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.41 |
| ▸ | PLK4 | O00444 | 3/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.40 |
| ▸ | CCR6 | P51684 | 1/20 | 0.40 |
| ▸ | AKT2 | P31751 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 2/20 | 0.39 |
| ▸ | PLK1 | P53350 | 1/20 | 0.39 |
| ▸ | MAP1LC3B | Q9GZQ8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2117957 | 0.86 | MEN1 (0.46) | MEN1KMT2ARETPDGFRBFGFR1 | |
| SCHEMBL2117260 | 0.83 | MEN1 (0.43) | MEN1KMT2ARETPDGFRBFGFR1 | |
| SCHEMBL2118294 | 0.82 | MEN1 (0.42) | MEN1KMT2ARETPDGFRBFGFR1 | |
| SCHEMBL2113633 | 0.77 | MEN1 (0.41) | MEN1KMT2ARETPDGFRBFGFR1 | |
| SCHEMBL1673441 | 0.76 | ALK (0.52) | MEN1KMT2ARETPDGFRBFGFR1 | |
| SCHEMBL2114024 | 0.76 | PDGFRB (0.45) | MEN1KMT2ARETPDGFRBFGFR1 | |
| SCHEMBL6326927 | 0.75 | BRD4 (0.34) | MEN1KMT2ARETKDR | |
| SCHEMBL2114496 | 0.75 | LRRK2 (0.42) | RETPDGFRBFGFR1KDRAKT2 | |
| SCHEMBL2117379 | 0.73 | KDR (0.42) | MEN1KMT2ARETPDGFRBFGFR1 | |
| SCHEMBL2114228 | 0.72 | SRC (0.45) | MEN1KMT2ARETPDGFRBFGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120094998-A1 | Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates | NEKTAR THERAPEUTICS (US) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120094998-A1 | Oligomer-Protein Tyrosine Kinase Inhibitor Conjugates | PTK2B, ERBB2, FRK | MEN1 2122/4885KMT2A 2372/4885RET 73/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.